Filtern
Volltext vorhanden
- ja (13)
Gehört zur Bibliographie
- ja (13)
Dokumenttyp
Sprache
- Englisch (13)
Schlagworte
- Human papillomavirus (2)
- T cells (2)
- inflammation (2)
- psoriasis (2)
- Anaphylaxis (1)
- B cells (1)
- Becker naevus (1)
- Becker naevus syndrome (1)
- Bowen’s disease, periungual (1)
- Cutaneous metastatic Crohn’s disease (1)
- Double sensitization (1)
- EVER1 (1)
- EVER2 (1)
- Field sting (1)
- Flt3L (1)
- Honey bee (1)
- Hymenoptera venom (1)
- IFN (1)
- IL‐10 (1)
- Immunotherapy (1)
- Kerinokeratosis papulosa (1)
- LIF (1)
- Nail unit (1)
- Nfatc1 (1)
- Relapse (1)
- Risk factor (1)
- Stevens-Johnson syndrome (1)
- Tr1 (1)
- Treatment failure (1)
- Vespula (1)
- Waxy papulosis of childhood (1)
- acitretin (1)
- activation (1)
- adverse event (1)
- anaphylaxis (1)
- anergy (1)
- bee (1)
- buildup phase (1)
- c-flip (1)
- cDC2 subset (1)
- cell-death (1)
- chemokine (1)
- conversion (1)
- dendritic cells (1)
- drug-induced liver injury (DILI) (1)
- eczematous dermatitis (1)
- fatty liver disease (1)
- gene induction (1)
- histologic findings (1)
- hymenoptera (1)
- hypoplasia of fatty tissue (1)
- in vivo (1)
- in-vivo (1)
- interleukins (1)
- keratinocytes (1)
- lichen planus (1)
- lower body (1)
- mediated apoptosis (1)
- pediatric (1)
- pityriasis rubra pilaris (1)
- programmed necrosis (1)
- risk factor (1)
- toxic epidermal necrolysis (1)
- treatment options (1)
- vespula (1)
Severe and prolonged liver damage in pityriasis rubra pilaris treated with acitretin: a case report
(2022)
Acitretin is a systemic retinoid that is used in dermatology for treatment of various inflammatory and especially hyperkeratotic diseases. Elevation of liver enzymes may occur occasionally but normally resolves spontaneously, at the latest after termination of acitretin. However, it can very rarely develop into a life-threatening adverse event including drug-induced liver injury (DILI). A 45-year-old man with classical pityriasis rubra pilaris, a frequently severe, inflammatory skin disease, was started on acitretin. After a seemingly harmless elevation of transaminases, a few weeks after initiation of acitretin, the patient experienced a dramatic course of liver injury with hepatic jaundice though acitretin was stopped immediately. Eventually, laboratory values recovered upon high-dose oral prednisolone therapy. Prescribing physicians should keep in mind that acitretin might induce severe liver injury. Even after termination of acitretin laboratory values should be monitored for a while in order to recognize symptomless but harmful drug-induced liver injury in time.